Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
WIndow Therapeutics
company
About
WIndow Therapeutics discovers and develops transformational therapeutics for cancer.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $256K
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2021
- Number Of Employee
- 1 - 10
- Operating Status
- Active
WIndow Therapeutics discovers and develops transformational therapeutics to address critical unmet patient needs in cancer and other life-threatening diseases. They develop breakthrough cancer therapeutics designed to penetrate and permeate into diseased tissue and exert activity specifically against cancer cells and not healthy ones.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$256K
WIndow Therapeutics has raised a total of
$256K
in funding over 2 rounds. Their latest funding was raised on
Feb 24, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 24, 2022 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
WIndow Therapeutics is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
